Resmed Inc. buy KeyCorp
Start price
06.02.24
/
50%
€178.25
Target price
06.02.25
€211.50
Performance (%)
28.64%
End price
07.02.25
€229.30
Summary
This prediction ended on 07.02.25 with a price of €229.30. The BUY prediction by KeyCorp finished with a performance of 28.64%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.87 was paid as dividends for this prediction. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -1.236% | -1.236% | -26.675% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten